Stephane Castel is the founder of Variant Bio. Variant Bio has raised $130M in total funding. Latest round: Series B. Based in Brooklyn, United States.
Stephane Castel is the Co-Founder and Chief Technology Officer of Variant Bio. Founded in 2018, the biotech company focuses on developing drugs using genetic insights from Indigenous populations. Castel leads the technology and scientific strategy at Variant Bio, which has raised over $130 million.
Full founder directory · Investor directory · Company funding database · Fundraising library